ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn's disease

Gastroenterology

Volumn 120, Issue 6, 2001, Pages 1347-1355

  Taylor, Kent D ^a   Plevy, Scott E ^b   Yang, Huiying ^a   Landers, Carol J ^a   Barry, Mary J ^c   Rotter, Jerome I ^a   Targan, Stephan R ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

^c Prometheus Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; LYMPHOTOXIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ANTIBODY;

ANTIBODY DETECTION; ARTICLE; CLINICAL TRIAL; CROHN DISEASE; DNA POLYMORPHISM; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0035050836     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2001.23966     Document Type: Article

References (52)

1. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease
2. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease: Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5
3. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells
4. Interleukin 12 and Th1 responses in inflammatory bowel disease
5. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: Expression and localization inintestinal mucosal cells
6. Bioactive IL-18 expression is up-regulated in Crohn's disease
7. A role for TNF-α and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease
8. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease
9. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: Prevalence and diagnostic role
10. Serologic testing for inflammatory bowel disease
11. Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup
12. Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics
13. Anti-Saccharomyces antibodies (ASCA) are highly positive in familial Crohn's disease
14. Evolving views of the major histocompatibility complex
15. Dense Alu clustering and a potential new member of the NF kappa B family within a 90 kilobase HLA class III segment
16. The MHC sequencing consortium. Complete sequence and gene map of a human major histocompatibility complex
17. DNA sequence polymorphism at the human tumor necrosis factor (TNF) locus: Numerous TNF/Lymphotoxin alleles tagged by two closely linked microsatellites in the upstream region of the lymphotoxin (TNFβ) gene
18. Highly informative typing of the human TNF locus using six adjacent polymorphic markers
19. Tumor necrosis factor microsatellites define a Crohn's disease-associated haplotype on chromosome 6
20. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by Ncol restriction of PCR product
21. The -308 tumor necrosis factor-alpha promoter polymorphism affects transcription
22. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood culture in healthy humans
23. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria
24. Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease
25. A polymorphic variation in a putative regulation box of the TNFA promoter region
26. Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles
27. Functional analysis of a human tumor necrosis factor alpha (TNF-alpha) promoter polymorphism related to joint damage in rheumatoid arthritis
28. Tumor necrosis factor alpha promoter polymorphism at position -238 is associated with chronic active hepatitis C infection
29. Tandem arrangement of genes coding for tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta) in the human genome
30. Polymorphic structure of the tumor necrosis factor (TNF) locus: An Ncol polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production
31. Genetic markers in clinically well defined patients with ulcerative colitis (UC)
32. Distinct associations of HLA class II genes with inflammatory bowel disease
33. Linkage of Crohn's disease to the MHC region is consistently detected by multiple nonparametric analyses
34. HLA class II haplotype associations with inflammatory bowel disease in Jewish (Ashkenazi) and non-Jewish Caucasian populations
35. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease
36. Base composition-independent hybridization in tetramethylammonium chloride: A method for oligonucleotide screening of highly complex gene libraries
37. The TNF-alpha gene Nco I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels
38. ASCA and pANCA do not predict response to anti-TNF alpha (Remicade) treatment
39. Tumor necrosis factor α antibody (Infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis
40. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: Implications for joint and gut-associated immunopathologies
41. Experimental models of inflammatory bowel disease
42. Experimental models to study molecular mechanisms underlying intestinal inflammation
43. Studies with IL-10 -/- mice: An overview
44. IL-12, but not IFN-gamma, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice
45. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4 sup+ TH1-like responses
46. pANCA represents a cross-reactivity to enteric bacterial antigens
47. Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers
48. Both the lymphotoxin and tumor necrosis factor pathways are involved in experimental murine models of colitis